High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models

…, M West, KM Whalen, V Zelesky, SX Zhao - Current drug …, 2008 - ingentaconnect.com
Evaluation and optimization of drug metabolism and pharmacokinetic data plays an important
role in drug discovery and development and several reliable in vitro ADME models are …

Discovery of N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment …

…, LH Gold, KK Cook, SB Sands, SX Zhao… - Journal of medicinal …, 2006 - ACS Publications
N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide (14, PHA-543,613), a
novel agonist of the α7 neuronal nicotinic acetylcholine receptor (α7 nAChR), has been …

Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with …

…, AS Kalgutkar, JR Soglia, SX Zhao - Chemical research in …, 2008 - ACS Publications
In vitro covalent binding assessments of drugs have been useful in providing retrospective
insights into the association between drug metabolism and a resulting toxicological response. …

Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4

…, ME Lame, KR Henne, J Soglia, SX Zhao… - Drug metabolism and …, 2005 - ASPET
The therapeutic benefits of the antidepressant nefazodone have been hampered by several
cases of acute hepatotoxicity/liver failure. Although the mechanism of hepatotoxicity remains …

Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 …

JN Bauman, JM Kelly, S Tripathy, SX Zhao… - Chemical research in …, 2009 - ACS Publications
In vitro covalent binding studies in which xenobiotics are shown to undergo metabolism-dependent
covalent binding to macromolecules have been commonly used to shed light on the …

NADPH-Dependent Covalent Binding of [3H]Paroxetine to Human Liver Microsomes and S-9 Fractions: Identification of an Electrophilic Quinone Metabolite of …

SX Zhao, DK Dalvie, JM Kelly, JR Soglia… - Chemical research in …, 2007 - ACS Publications
The primary pathway of clearance of the methylenedioxyphenyl-containing compound and
selective serotonin reuptake inhibitor paroxetine in humans involves P450 2D6-mediated …

Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and …

…, ADN Vaz, C Collin, JR Soglia, SX Zhao… - Chemico-biological …, 2005 - Elsevier
Therapy with the antidepressant trazodone has been associated with several cases of
idiosyncratic hepatotoxicity. While the mechanism of hepatotoxicity remains unknown, it is …

A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4 …

AS Kalgutkar, J Driscoll, SX Zhao… - Chemical research in …, 2007 - ACS Publications
The current study examined the bioactivation potential of a nonpeptidyl thrombopoietin
receptor agonist, 1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)…

Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure–activity relationships and strategies for the elimination of reactive …

…, FC Bi, AS Kalgutkar, JN Bauman, SX Zhao… - Bioorganic & medicinal …, 2008 - Elsevier
The synthesis and SAR for a series of diaminopyrimidines as PYK2 inhibitors are described.
Using a combination of library and traditional medicinal chemistry techniques, a FAK-…

Discovery Tactics To Mitigate Toxicity Risks Due to Reactive Metabolite Formation with 2-(2-Hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one …

…, MT Didiuk, KS Frederick, SX Zhao… - Chemical research in …, 2010 - ACS Publications
The synthesis and structure−activity relationship studies on 5-trifluoromethylpyrido[4,3-d]pyrimidin-4(3H)-ones
as antagonists of the human calcium receptor (CaSR) have been recently …